Ixochymostatin, a trypsin inhibitor-like (TIL) protein from Ixodes scapularis, inhibits chymase and impairs vascular permeability
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
39579814
DOI
10.1016/j.ijbiomac.2024.137949
PII: S0141-8130(24)08760-9
Knihovny.cz E-resources
- Keywords
- Chymase, Inhibitor, Ixodes scapularis, Tick saliva, Trypsin inhibitor-like,
- MeSH
- Chymases * metabolism chemistry antagonists & inhibitors MeSH
- Trypsin Inhibitors pharmacology chemistry metabolism MeSH
- Capillary Permeability * drug effects MeSH
- Ixodes * metabolism MeSH
- Humans MeSH
- Mice MeSH
- Arthropod Proteins chemistry pharmacology metabolism MeSH
- Amino Acid Sequence MeSH
- Salivary Glands metabolism drug effects MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Chymases * MeSH
- Trypsin Inhibitors MeSH
- Arthropod Proteins MeSH
Ticks obtain a blood meal by lacerating small blood vessels and ingesting the blood that flows to the feeding site, which triggers various host responses. However, ticks face the challenge of wound healing, a process involving hemostasis, inflammation, cell proliferation and migration, and remodeling, hindering blood acquisition. To overcome these obstacles, tick salivary glands produce an array of bioactive molecules. Here, we characterize ixochymostatin, an Ixodes scapularis protein belonging to the trypsin inhibitor-like (TIL) family. It is expressed in multiple developmental stages and in tick salivary glands and acts as a slow and tight-binding inhibitor of chymase, cathepsin G, and chymotrypsin. Predictions for the tertiary structure complex between ixochymostatin and chymase suggest a direct interaction between the inhibitor reactive site loop and protease active sites. In vitro, ixochymostatin protects the endothelial cell barrier against chymase degrading action, decreasing cell permeability. In vivo, it reduces vascular permeability induced by chymase and compound 48/80, a mast cell degranulator agonist, in a mouse model. Additionally, ixochymostatin inhibits the chymase-dependent generation of vasoconstrictor peptides. Antibodies against ixochymostatin neutralize its inhibitory properties, with epitope mapping identifying potential neutralization regions. Ixochymostatin emerges as a novel tick protein modulating host responses against tick feeding, facilitating blood acquisition.
References provided by Crossref.org